Skip to main content

Advertisement

Log in

Understanding the Cancer Pain Experience

  • Cancer Pain (D Marcus, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Cancer pain management is a major element of successful cancer survivorship. Regardless of where someone is along the cancer experience, from a newly diagnosed patient to long-term survivor, pain is a potential treatment-related effect that can have a significant impact on a survivor’s life. Quality pain management for cancer survivors is complicated by the fact that cancer-related pain can be due to the tumor, surgery, radiation, and/or chemotherapy. Additionally, the pain experience is related to many psychosocial/spiritual factors. Despite almost 40 years of attention devoted to improving cancer pain management, many cancer survivors are less than optimally treated, often owing to survivor and healthcare provider knowledge barriers. This article reviews some of the latest research related to cancer pain management treatment options, measurement/assessment, and interventions. Progress has been made in understanding new aspects of the pain experience, but more work is yet to be done.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Doorenbos AZ, Berger AM, Brohard-Holbert C, Eaton L, Kozachik S, LoBiondo-Wood G, et al. 2008 ONS research priorities survey. Oncol Nurs Forum. 2008;35:E100–7.

    Article  PubMed  Google Scholar 

  2. National Cancer Institute. Pain (PDQ) - Health Professional Version. 2013. Available at: http://www.cancer.gov/cancertopics/pdq/supportivecare/pain/HealthProfessional. Accessed 1 Oct 2013.

  3. American Cancer Society. Cancer treatment and survivorhsip facts & figures 2012–2013. Atlanta: American Cancer Society; 2012.

    Google Scholar 

  4. Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011.

    Google Scholar 

  5. Sessle B. Unrelieved pain: a crisis. Pain Res Manag. 2011;16:416–20.

    PubMed Central  PubMed  Google Scholar 

  6. Schreiber JA. We’ve come a long way…cancer pain management review: oncology Nursing Forum/Newsletter 1973–2013. Oncol Nurs Forum. 2013;40:106–8.

    Article  PubMed  Google Scholar 

  7. Dunham M, Ingleton C, Ryan T, Gott M. A narrative literature review of older people's cancer pain experience. J Clin Nurs. 2013;22:2100–13.

    Article  PubMed  Google Scholar 

  8. Pizzo PA, Clark NM. Alleviating suffering 101—pain relief in the United States. N Engl J Med. 2012;366:197–9.

    Article  CAS  PubMed  Google Scholar 

  9. Bredlau AL, Thakur R, Korones DN, Dworki RH. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2014;14:505–17. This review is the first on the use of ketamine in adult and pediatric cancer patients. Findings are limited owing to the variability of the dosing and routes in the studies reviewed.

    Google Scholar 

  10. Hardy J, Quinn S, Fazekas B, Plummer J, Eckermann S, Agar M, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30:3611–7.

    Article  CAS  PubMed  Google Scholar 

  11. Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2012;11, CD003351.

    PubMed  Google Scholar 

  12. Prommer EE. Ketamine for pain: an update of uses in palliative care. J Palliat Med. 2012;15:474–83.

    Article  PubMed  Google Scholar 

  13. Soto E, Stewart DR, Mannes AJ, Ruppert SL, Baker K, Zlott D, et al. Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Med. 2012;29:308–17.

    Article  Google Scholar 

  14. Salas S, Frasca M, Planchet-Barraud B, Burucoa B, Pascal M, Lapiana J-M, et al. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. J Palliat Med. 2012;15:287–93.

    PubMed  Google Scholar 

  15. Macario A, Royal MA. A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain. Pain Pract. 2011;11:290–6.

    Article  PubMed  Google Scholar 

  16. Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012;26:305–12.

    Article  PubMed  Google Scholar 

  17. Hadley G, Derry S, Moore RA, Wiffen PJ. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev. 2013;10, CD010270.

    PubMed  Google Scholar 

  18. Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. J Pain Symptom Manag. 2013;46:573–80.

    Article  Google Scholar 

  19. Zeppetella G, Davies A, Eijgelshoven I, Jansen JP. A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manag. 2014;47:772–85.

    Article  Google Scholar 

  20. Guitart J, Vargas I, Sanctis V, Ferreras J, Fuentes J, Salazar R, et al. Efficacy and safety of sublingual fentanyl orally disintegrating tablets in patients with breakthrough pain: multicentre prospective study. Clin Drug Investig. 2013;33:675–83.

    Article  CAS  PubMed  Google Scholar 

  21. Taylor DR. Single-does fentanyl sublingual spry for breakthrough cancer pain. Clin Pharmacol. 2013;5:131–41.

    PubMed Central  PubMed  Google Scholar 

  22. Velázquez Rivera I, Muñoz Garrido J, García Velasco P, España Ximénez de Enciso I, Velázquez Clavarana L. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain. Adv Ther. 2014;31:107–17.

    Article  PubMed  Google Scholar 

  23. Mercadante S, Porzio G, Aielli F, Averna L, Ficorella C, Casuccio A. The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting. Support Care Cancer. 2013;21:2335–9.

    Article  PubMed  Google Scholar 

  24. Webster LR, Slevin KA, Narayana A, Earl CQ, Yang R. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes. Pain Med. 2013;14:1332–45.

    Article  PubMed  Google Scholar 

  25. Mercadante S, Prestia G, Adile C, Casuccio A. Intranasal fentanyl (INFS) versus fentanyl pectyn nasal spray (FPNS) for the management breakthrough cancer pain in doses proportional to basal opioid regimen. J Pain. 2014;15:602–7.

    Article  CAS  PubMed  Google Scholar 

  26. Kongsgaard U, Eeg M, Greisen H. The use of Instanyl® in the treatment of breakthrough pain in cancer patients: a 3-month observational, prospective, cohort study. Support Care Cancer. 2014:1–8.

  27. Rhee YO, Kim E, Kim B. Assessment of pain and analgesic use in African American cancer patients: factors related to adherence to analgesics. J Immigr Minor Health. 2012;14:1045–51.

    Article  PubMed  Google Scholar 

  28. Schreiber JA, Cantrell D, Moe KA, Hench J, McKinney E, Preston Lewis C, et al. Improving knowledge, assessment, and attitudes related to pain management: evaluation of an intervention. Pain Manag Nurs. 2014;5:474–81.

    Article  Google Scholar 

  29. Modesto-Lowe V, Girard L, Chaplin M. Cancer pain in the opioid-addicted patient: can we treat it right? J Opioid Manag. 2012;8:167–75. This review focuses on adequate cancer pain management strategies in opiod-addicted cancer paitents.

    Article  PubMed  Google Scholar 

  30. Samuels JG. Abstracting pain management documentation from the electronic medical record: comparison of three hospitals. Appl Nurs Res. 2012;25:89–94.

    Article  PubMed  Google Scholar 

  31. Ngamkham S, Vincent C, Finnegan L, Holden JE, Wang ZJ, Wilkie DJ. The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review. Pain Manag Nurs. 2012;13:27–51.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, et al. A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012;118:6278–86.

    Article  PubMed  Google Scholar 

  33. Hovind IL, Bredal IS, Dihle A. Women’s experience of acute and chronic pain following breast cancer surgery. J Clin Nurs. 2013;22:1044–52.

    Article  PubMed  Google Scholar 

  34. Knudsen AK, Aass N, Heitzer E, Klepstad P, Hjermstad MJ, Schippinger W, et al. Interviews with patients with advanced cancer—another step towards an international cancer pain classification system. Support Care Cancer. 2012;20:2491–500. Although a small sample of patients, the differences in patients’ ranking of pain domains compared to healthcare professionals is noteworthy.

    Article  PubMed  Google Scholar 

  35. Al Khalaileh M, Al Qadire M. Barriers to cancer pain management: Jordanian nurses’ perspectives. Int J Palliat Nurs. 2012;18:535–6.

    Article  PubMed  Google Scholar 

  36. Jablonski K, Duke G. Pain management in persons who are terminally ill in rural acute care. J Hosp Palliat Nurs. 2012;14:533–40.

    Article  Google Scholar 

  37. Rustoen T, Geerling JI, Pappa T, Rundstrom C, Weisse I, Williams SC, et al. A European survey of oncology nurse breakthrough cancer pain practices. Eur J Oncol Nurs. 2013;17:95–100. This RCT did not find a difference between an extended (10-week) pain management program and standard care in decreasing pain intensity.

    Article  PubMed  Google Scholar 

  38. Yoong J, Traeger LN, Gallagher ER, Pirl WF, Greer JA, Temel JS. A pilot study to investigate adherence to long-acting opioids among patients with advanced lung cancer. J Palliat Med. 2013;16:391–6.

    Article  PubMed  Google Scholar 

  39. Ling CC, Lui LY, So WK. Do educational interventions improve cancer patients’ quality of life and reduce pain intensity? Quantitative systematic review. J Adv Nurs. 2012;68:511–20.

    Article  PubMed  Google Scholar 

  40. Tse MM, Wong AC, Ng HN, Lee HY, Chong MH, Leung WY. The effect of a pain management program on patients with cancer pain. Cancer Nurs. 2012;35:438–46.

    Article  PubMed  Google Scholar 

  41. Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E. Supporting self-management of pain in cancer patients: methods and lessons learned from a randomized controlled pilot study. Eur J Oncol Nurs. 2013;17:1–8.

    Article  PubMed  Google Scholar 

  42. Rustoen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C. A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management. Cancer Nurs. 2014;37:34–43.

    Article  PubMed  Google Scholar 

  43. Rustoen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C. The PRO-SELF© Pain Control Program improves patients’ knowledge of cancer pain management. J Pain Symptom Manag. 2012;44:321–30.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Judith Schreiber declares no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judith A. Schreiber.

Additional information

This article is part of the Topical Collection on Cancer Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schreiber, J.A. Understanding the Cancer Pain Experience. Curr Pain Headache Rep 18, 440 (2014). https://doi.org/10.1007/s11916-014-0440-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-014-0440-5

Keywords

Navigation